IL17A and amyloidosis: To determine whether the propionate-mediated reductions in reactive astrocytosis and amyloidosis were dependent on IL-17 signaling, we treated male and female APPPS1-21 mice with an IL-17 mAb or IgG1 control to reduce the levels of peripheral IL-17.